Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - European journal of …, 2020 - Wiley Online Library
The co‐occurrence of cancer and heart failure (HF) represents a significant clinical
drawback as each disease interferes with the treatment of the other. In addition to shared …
drawback as each disease interferes with the treatment of the other. In addition to shared …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - European Journal of …, 2020 - europepmc.org
The co‐occurrence of cancer and heart failure (HF) represents a significant clinical
drawback as each disease interferes with the treatment of the other. In addition to shared …
drawback as each disease interferes with the treatment of the other. In addition to shared …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - European journal of …, 2020 - epublications.vu.lt
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - European journal of …, 2020 - folia.unifr.ch
English The co-occurrence of cancer and heart failure (HF) represents a significant clinical
drawback as each disease interferes with the treatment of the other. In addition to shared …
drawback as each disease interferes with the treatment of the other. In addition to shared …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - European Journal of …, 2020 - experts.umn.edu
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
R Boer, J Hulot, CG Tocchetti… - European Journal of …, 2020 - hal.science
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - 2020 - publications.goettingen-research …
The co‐occurrence of cancer and heart failure (HF) represents a significant clinical
drawback as each disease interferes with the treatment of the other. In addition to shared …
drawback as each disease interferes with the treatment of the other. In addition to shared …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
RA de Boer, JS Hulot, CG Tocchetti… - … journal of heart …, 2020 - pubmed.ncbi.nlm.nih.gov
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
[PDF][PDF] Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure …
RA de Boer, JS Hulot, CG Tocchetti - ESC, 2020 - scholar.archive.org
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …
A Bayés-Genís, RA de Boer, JS Hulot… - … Journal of Heart …, 2020 - portalrecerca.uab.cat
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …
as each disease interferes with the treatment of the other. In addition to shared risk factors, a …